About this Journal Submit a Manuscript Table of Contents
International Journal of Biomedical Imaging
Volume 2011 (2011), Article ID 370701, 8 pages
http://dx.doi.org/10.1155/2011/370701
Review Article

Molecular Imaging in Tumor Angiogenesis and Relevant Drug Research

Intelligent Medical Research Center, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China

Received 9 March 2011; Revised 16 May 2011; Accepted 23 May 2011

Academic Editor: Habib Zaidi

Copyright © 2011 Xibo Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. K. Willmann, N. Bruggen, L. M. Dinkelborg, and S. S. Gambhir, “Molecular imaging in drug development,” Nature Reviews Drug Discovery, vol. 7, no. 7, pp. 591–606, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Hargreaves, “The role of molecular imaging in drug discovery and development,” Clinical Pharmaclology & Therapeutics, vol. 82, no. 2, pp. 349–353, 2007.
  3. A. Iagaru, X. Chen, and S. S. Gambhir, “Molecular imaging can accelerate anti-angiogenic drug development and testing,” Nature Clinical Practice Oncology, vol. 4, no. 10, pp. 556–557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Scopus
  5. W. Cai, J. Rao, S. S. Gambhir, and X. Chen, “How molecular imaging is speeding up antiangiogenic drug development,” Molecular Cancer Therapeutics, vol. 5, no. 11, pp. 2624–2633, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. X. B. Ma, Z. F. Liu, and X. Yang, “Dual-modality monitoring of tumor response to cyclophosphamide therapy in mice with bioluminescence imaging and small-animal positron emission tomography,” Molecular Imaging, vol. 10, no. 4, pp. 278–283, 2011.
  7. H. Prenen, C. Stefan, and A. Oosterom, “Imatinib mesylate inhibits glucose uptake in gastrointestinal stromal tumor cells by downregulation of the glucose transporters recruitment to the plasma membrane,” American Journal of Biochemistry and Biotechnology, vol. 1, no. 2, pp. 95–102, 2005.
  8. G. D. Luker and K. E. Luker, “Optical imaging: current applications and future directions,” Journal of Nuclear Medicine, vol. 49, no. 1, pp. 1–4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. K. E. Luker and D. Piwnica-Worms, “Optimizing luciferase protein fragment complementation for bioluminescent imaging of protein-protein interactions in live cells and animals,” Methods in Enzymology, vol. 385, pp. 349–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. F. Massoud, R. Paulmurugan, P. Ray, and S. S. Gambhir, “Reporter gene imaging of protein-protein interactions in living subjects,” Current Opinion in Biotechnology, vol. 18, no. 1, pp. 31–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. T. F. Massoub, R. Paulmurugan, and S. S. Gambhir, “Molecular imaging of homodimeric protein-protein interactions in living subjects,” Federation of American Societies for Experimental Biology Journal, vol. 18, no. 10, pp. 1105–1107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Paulmurugan and S. S. Gambhir, “An intramolecular folding sensor for imaging estrogen receptor-ligand interactions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 43, pp. 15883–15888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Paulmurugan and S. S. Gambhir, “Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system for studying protein-protein interactions,” Analytical Chemistry, vol. 79, no. 6, pp. 2346–2353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Paulmurugan, T. F. Massoud, J. Huang, and S. S. Gambhir, “Molecular imaging of drug-modulated protein-protein interactions in living subjects,” Cancer Research, vol. 64, no. 6, pp. 2113–2119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Paulmurugan, P. Ray, A. De, C. T. Chan, and S. S. Gambhir, “Imaging protein-protein interactions in living animals,” in Protein–Protein Interactions: A Molecular Cloning Manual, E. Golemis and P. D. Adams, Eds., vol. 1, pp. 695–713, Cold Spring Harbor Laboratory Press, New York, NY, USA, 2nd edition, 2005.
  16. R. Paulmurugan, P. Ray, A. De, C. T. Chan, and S. S. Gambhir, “Imaging protein-protein interactions in living subjects,” Trends in Analytical Chemistry, vol. 24, no. 5, pp. 446–458, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Paulmurugan, Y. Umezawa, and S. S. Gambhir, “Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15608–15613, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. G. D. Luker, V. Sharma, and D. W. Piwnica, “Visualizing protein-protein interactions in living animals,” Methods, vol. 29, no. 1, pp. 110–122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Villalobos, S. Naik, and D. Piwnica-Worms, “Current state of imaging protein-protein interactions in vivo with genetically encoded reporters,” Annual Review of Biomedical Engineering, vol. 9, pp. 321–349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Paulmurugant and S. S. Gambhir, “Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation,” Analytical Chemistry, vol. 75, no. 7, pp. 1584–1589, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. K. E. Luker, M. C. P. Smith, G. D. Luker, S. T. Gammon, H. Piwnica-Worms, and D. Piwnica-Worms, “Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 33, pp. 12288–12293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Paulmurugan and S. S. Gambhir, “Novel fusion protein approach for efficient high-throughput screening of small molecule-mediating protein-protein interactions in cells and living animals,” Cancer Research, vol. 65, no. 16, pp. 7413–7420, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Remy and S. W. Michnick, “A highly sensitive protein-protein interaction assay based on Gaussia luciferase,” Nature Methods, vol. 3, no. 12, pp. 977–979, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. G. D. Luker, C. M. Pica, J. Song, K. E. Luker, and D. Piwnica-Worms, “Imaging 26S proteasome activity and inhibition in living mice,” Nature Medicine, vol. 9, no. 7, pp. 969–973, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. G. J. Zhang, M. Safran, W. Wei et al., “Bioluminescent imaging of Cdk2 inhibition in vivo,” Nature Medicine, vol. 10, no. 6, pp. 643–648, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Safran, W. Y. Kim, F. O'Connell et al., “Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 1, pp. 105–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Funovics, R. Weissleder, and C. H. Tung, “Protease sensors for bioimaging,” Analytical and Bioanalytical Chemistry, vol. 377, no. 6, pp. 956–963, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Grimm, D. G. Kirsch, S. D. Windsor et al., “Use of gene expression profiling to direct in vivo molecular imaging of lung cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 40, pp. 14404–14409, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Jiang, E. S. Olson, Q. T. Nguyen, M. Roy, P. A. Jennings, and R. Y. Tsien, “Tumor imaging by means of proteolytic activation of cell-penetrating peptides,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 51, pp. 17867–17872, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Tian, J. Xue, Y. Dai, J. Chen, and J. Zheng, “A novel software platform for medical image processing and analyzing,” IEEE Transactions on Information Technology in Biomedicine, vol. 12, no. 6, pp. 800–812, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Lv, J. Tian, W. Cong et al., “A multilevel adaptive finite element algorithm for bioluminescence tomography,” Optics Express, vol. 14, no. 18, pp. 8211–8223, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. S. Gambhir, “Molecular imaging of cancer with positron emission tomography,” Nature Reviews Cancer, vol. 2, no. 9, pp. 683–693, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Bombardieri, “The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 7, pp. 753–758, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Belhocine, N. Steinmetz, R. Hustinx et al., “Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis,” Clinical Cancer Research, vol. 8, no. 9, pp. 2766–2774, 2002. View at Scopus
  35. H. H. Boersma, B. L. J. H. Kietselaer, L. M. L. Stolk et al., “Past, present, and future of annexin A5: from protein discovery to clinical applications,” Journal of Nuclear Medicine, vol. 46, no. 12, pp. 2035–2050, 2005. View at Scopus
  36. L. Wang, J. Shi, Y. S. Kim et al., “Improving tumor-targeting capability and pharmacokinetics of 99Tc-labeled cyclic RGD dimers with PEG4 linkers,” Molecular Pharmaceutics, vol. 6, no. 1, pp. 231–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. R. Cherry, “In vivo molecular and genomic imaging: new challenges for imaging physics,” Physics in Medicine and Biology, vol. 49, no. 3, pp. R13–R48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. L. A. Feldkamp, L. C. Davis, and J. W. Kress, “Practical cone-beam algorithm,” Journal of the Optical Society of America A, vol. 1, no. 6, pp. 612–619, 1984. View at Scopus
  39. E. L. Ritman, “Molecular imaging in small animals roles for micro-CT,” Journal of Cellular Biochemistry, no. 39, pp. 116–124, 2002. View at Scopus
  40. N. Ferrara, “VEGF and the quest for tumour angiogenesis factors,” Nature Reviews Cancer, vol. 2, no. 10, pp. 795–803, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. A. D. Izzo, M. A. Mackanos, J. T. Beckham, and E. D. Jansen, “In vivo optical imaging of expression of vascular endothelial growth factor following laser incision in skin,” Lasers in Surgery and Medicine, vol. 29, no. 4, pp. 343–350, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Wang, M. Iyer, A. Annala, L. Wu, M. Carey, and S. S. Gambhir, “Noninvasive indirect imaging of vascular endothelial growth factor gene expression using bioluminescence imaging in living transgenic mice,” Physiological Genomics, vol. 24, no. 2, pp. 173–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. A. R. Hsu, W. B. Cai, A. Veeravagu et al., “Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel,” Journal of Nuclear Medicine, vol. 48, no. 3, pp. 445–454, 2007. View at Scopus
  44. S. R. Cherry, Y. Shao, R. W. Silverman et al., “MicroPET: a high resolution PET scanner for imaging small animals,” IEEE Transactions on Nuclear Science, vol. 44, no. 3, pp. 1161–1166, 1997. View at Scopus
  45. A. F. Chatziioannou, S. R. Cherry, Y. Shao et al., “Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging,” Journal of Nuclear Medicine, vol. 40, no. 7, pp. 1164–1175, 1999. View at Scopus
  46. D. R. Collingridge, V. A. Carroll, M. Glaser et al., “The development of [124I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography,” Cancer Research, vol. 62, no. 20, pp. 5912–5919, 2002. View at Scopus
  47. W. Cai, K. Chen, K. A. Mohamedali et al., “PET of vascular endothelial growth factor receptor expression,” Journal of Nuclear Medicine, vol. 47, no. 12, pp. 2048–2056, 2006. View at Scopus
  48. A. R. Hsu, W. Cai, A. Veeravagu et al., “Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel,” Journal of Nuclear Medicine, vol. 48, no. 3, pp. 445–454, 2007. View at Scopus
  49. E. Lu, W. R. Wagner, U. Schellenberger et al., “Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue,” Circulation, vol. 108, no. 1, pp. 97–103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. M. V. Backer, Z. Levashova, V. Patel et al., “Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes,” Nature Medicine, vol. 13, no. 4, pp. 504–509, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. F. G. Blankenberg, S. Mandl, Y. A. Cao et al., “Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor,” Journal of Nuclear Medicine, vol. 45, no. 8, pp. 1373–1380, 2004. View at Scopus
  52. Z. Liu, F. Wang, and X. Chen, “Integrin αvβ3-targeted cancer therapy,” Drug Development Research, vol. 69, no. 6, pp. 329–339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Jia, J. Shi, Z. Yang et al., “99Tc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin αvβ3 expression,” Bioconjugate Chemistry, vol. 17, no. 4, pp. 1069–1076, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. Q. He, Z. Liu, B. Jia et al., “In vivo gamma imaging of the secondary tumors of transplanted human fetal striatum neural stem cells-derived primary tumor cells,” NeuroReport, vol. 19, no. 10, pp. 1009–1014, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. Z. Liu, S. Liu, F. Wang, S. Lieu, and X. Chen, “Noninvasive imaging of tumor integrin expression using 18F- labeled RGD dimer peptide with PEG4 linkers,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 8, pp. 1296–1307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Liu, Z. Liu, K. Chen et al., “18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression,” Molecular Imaging and Biology, vol. 12, no. 5, pp. 530–538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. Z. F. Liu, G. Niu, J. Shi, et al., “68Ga-labeled cyclic RGD dimmers with Gly3PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, pp. 947–957, 2010.
  58. F. Cao, Z. Li, A. Lee et al., “Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation,” Cancer Research, vol. 69, no. 7, pp. 2709–2713, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Veeravagu, Z. Liu, G. Niu et al., “Integrin αvβ3-targeted radioimmunotherapy of glioblastoma multiforme,” Clinical Cancer Research, vol. 14, no. 22, pp. 7330–7339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. Z. F. Liu, B. Jia, H. Y. Zhao, X. Y. Chen, and F. Wang, “Specific targeting of human integrin αvβ3 with 111In -labeled abegrinTM in nude mouse models,” Molecular Imaging and Biology, vol. 13, no. 1, pp. 112–120, 2011.
  61. Z. Liu, S. Liu, G. Niu, F. Wang, and X. Chen, “Optical imaging of integrin αvβ3 expression with near- infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers,” Molecular Imaging, vol. 9, no. 1, pp. 21–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. J. D. Hood and D. A. Cheresh, “Role of integrins in cell invasion and migration,” Nature Reviews Cancer, vol. 2, no. 2, pp. 91–100, 2002. View at Scopus
  63. J. P. Xiong, T. Stehle, R. Zhang et al., “Crystal structure of the extracellular segment of integrin αvβ3 in complex with an Arg-Gly-Asp ligand,” Science, vol. 296, no. 5565, pp. 151–155, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. W. Cai and X. Chen, “Anti-angiogenic cancer therapy based on integrin αvβ3 antagonism,” Anti-Cancer Agents in Medicinal Chemistry, vol. 6, no. 5, pp. 407–428, 2006. View at Scopus
  65. J. P. Xiong, T. Stehle, B. Diefenbach et al., “Crystal structure of the extracettutar segment of integrin αvβ3,” Science, vol. 294, no. 5541, pp. 339–345, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. W. Cai, S. S. Gambhir, and X. Chen, “Multimodality tumor imaging targeting integrin αvβ3,” BioTechniques, vol. 39, no. 6, pp. S14–S25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Achilefu, S. Bloch, M. A. Markiewicz et al., “Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 22, pp. 7976–7981, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Ye, S. Bloch, B. Xu, and S. Achilefu, “Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors,” Journal of Medicinal Chemistry, vol. 49, no. 7, pp. 2268–2275, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. X. B. Ma, J. Tian, C. H. Qin, et al., “Early detection of liver cancer based on bioluminescent tomography,” Applied Optics, vol. 50, no. 10, pp. 1389–1395, 2011.